RVL Pharmaceuticals plc Profit Margin

The latest profit margin for RVLP is -184.91% as of June 2023. That compares with -161.69% in the prior-year period — down 14.4% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside RVL Pharmaceuticals plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, RVLP's profit margin moved from -161.69% to -184.91% — a 14.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RVL Pharmaceuticals plc's valuation or profitability profile.

Against Healthcare companies, RVLP currently prints -184.91% for profit margin, while the sector average sits near 13.89%. That is roughly 1430.9% below the sector mean. Large gaps often invite a closer look at RVL Pharmaceuticals plc's growth, margins, and balance sheet.

Profit Margin shows how effectively RVL Pharmaceuticals plc converts resources into returns. At -184.91%, RVLP may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -161.69% in the prior-year period — down 14.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RVLP's profit margin (-184.91%), review year-over-year change from -161.69%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.